Elaina buys VRX 120.52: Valeant Pharmaceuticals Intl Receives Consensus Recommendation of âBuyâ from Brokerages (NYSE:VRX)
Valeant Pharmaceuticals Intl (NYSE:VRX) has received a consensus rating of âBuyâ from the seventeen analysts that are presently covering the stock, American Banking and Market News reports. One analyst has rated the stock with a hold rating, twelve ... ...
44 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home